Balance Sheet XPeng Inc.

Equities

XPEV

US98422D1054

Auto & Truck Manufacturers

Market Closed - Nyse Other stock markets 04:00:02 2025-01-14 pm EST			After market 07:54:51 pm
12.61 ^USD	+6.77%		12.64	+0.20%

Jan. 14	Top Midday Stories: Eli Lilly Guides Q4 Revenue Below Consensus; Meta Platforms Reportedly Plans to Cut 5% of Lowest Performers	MT
Jan. 14	Chinese Stocks Advance on News of Gradual Tariff Increases Under Trump Administration	MT

770186fe82cbfaee34ba.Ux7QEkfy8j9BRwJGhhmZjSMeexvlYBGCtslLzz_aW34.MieEKyvLuwYwA3QVtSjPtVprQinQJHXjgL0sukjtKA0YcaQkPpexVQRxVw

Published financial data: XPENG INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	2.32B	5.84B	20.99B	26.86B	30.68B
Total Revenues	2.32B	5.84B	20.99B	26.86B	30.68B
Cost of Goods Sold, Total	2.8B	5.52B	18.33B	23.74B	30.14B
Gross Profit	-479M	329M	2.66B	3.12B	533M
Selling General & Admin Expenses, Total	1.16B	2.92B	5.31B	6.69B	6.56B
R&D Expenses	2.07B	1.73B	4.11B	5.21B	5.28B
Other Operating Expenses	-12.29M	-86.83M	-84.88M	-109M	-466M
Other Operating Expenses, Total	3.22B	4.56B	9.33B	11.79B	11.37B
Operating Income	-3.7B	-4.23B	-6.68B	-8.67B	-10.84B
Interest Expense, Total	-32.02M	-22.45M	-55.34M	-132M	-269M
Interest And Investment Income	88.84M	133M	743M	1.06B	1.26B
Net Interest Expenses	56.83M	111M	688M	927M	991M
Income (Loss) On Equity Invest.	-	-	-	4.12M	54.74M
Currency Exchange Gains (Loss)	8.4M	81.2M	384M	-1.46B	97.08M
Other Non Operating Income (Expenses)	23.68M	1.37B	79.26M	95.68M	-368M
EBT, Excl. Unusual Items	-3.61B	-2.67B	-5.53B	-9.11B	-10.06B
Gain (Loss) On Sale Of Investments	-	-	592M	25.06M	-224M
Asset Writedown	-79.18M	-63.25M	-34.59M	-30.85M	-81.81M
Other Unusual Items	-	-	133M	-	29.34M
EBT, Incl. Unusual Items	-3.69B	-2.73B	-4.84B	-9.11B	-10.34B
Income Tax Expense	1K	1.22M	25.99M	24.73M	36.81M
Earnings From Continuing Operations	-3.69B	-2.73B	-4.86B	-9.14B	-10.38B
Net Income to Company	-3.69B	-2.73B	-4.86B	-9.14B	-10.38B
Net Income - (IS)	-3.69B	-2.73B	-4.86B	-9.14B	-10.38B
Preferred Dividend and Other Adjustments	951M	2.16B	-	-	-
Net Income to Common Incl Extra Items	-4.64B	-4.89B	-4.86B	-9.14B	-10.38B
Net Income to Common Excl. Extra Items	-4.64B	-4.89B	-4.86B	-9.14B	-10.38B
Per Share Items
Net EPS - Basic	-26.57	-12.97	-5.92	-10.67	-11.92
Basic EPS - Continuing Operations	-26.57	-12.97	-5.92	-10.67	-11.92
Basic Weighted Average Shares Outstanding	175M	377M	821M	856M	870M
Net EPS - Diluted	-26.57	-12.97	-5.92	-10.67	-11.92
Diluted EPS - Continuing Operations	-26.57	-12.97	-5.92	-10.67	-11.92
Diluted Weighted Average Shares Outstanding	175M	377M	821M	856M	870M
Normalized Basic EPS	-12.92	-4.42	-4.21	-6.65	-7.22
Normalized Diluted EPS	-12.92	-4.42	-4.21	-6.65	-7.22
American Depositary Receipts Ratio (ADR)	2	2	2	2	2
Supplemental Items
EBITDA	-3.56B	-3.9B	-6.07B	-7.71B	-8.91B
EBITA	-3.69B	-4.2B	-6.64B	-8.62B	-10.56B
EBIT	-3.7B	-4.23B	-6.68B	-8.67B	-10.84B
EBITDAR	-3.43B	-3.74B	-5.62B	-6.8B	-8.09B
Total Revenues (As Reported)	2.32B	5.84B	20.99B	26.86B	30.68B
Effective Tax Rate - (Ratio)	0	-0.04	-0.54	-0.27	-0.36
Current Domestic Taxes	1K	-	-	-	-
Total Current Taxes	1K	1.22M	25.99M	24.73M	18.01M
Total Deferred Taxes	-	-	-	-	18.8M
Normalized Net Income	-2.26B	-1.67B	-3.45B	-5.69B	-6.29B
Interest Capitalized	38.48M	26.35M	10.6M	85M	107M
Interest on Long-Term Debt	-	-	-	22.85M	40.2M
Supplemental Operating Expense Items
Marketing Expenses	168M	517M	873M	578M	414M
Selling and Marketing Expenses	168M	517M	873M	578M	414M
Research And Development Expense From Footnotes	2.07B	1.73B	4.11B	5.21B	5.28B
Net Rental Expense, Total	128M	161M	453M	911M	821M
Imputed Operating Lease Interest Expense	34.65M	25.65M	66.08M	178M	175M
Imputed Operating Lease Depreciation	93.55M	136M	387M	733M	646M
Stock-Based Comp., COGS (Total)	-	-	-	3.18M	3.24M
Stock-Based Comp., R&D Exp. (Total)	-	318M	225M	425M	340M
Stock-Based Comp., SG&A Exp. (Total)	517K	678M	155M	283M	207M
Total Stock-Based Compensation	517K	996M	380M	710M	551M

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	1.95B	29.21B	11.02B	14.61B	21.13B
Short Term Investments	596M	3.83B	28.78B	16.7B	17.72B
Total Cash And Short Term Investments	2.54B	33.04B	39.8B	31.31B	38.85B
Accounts Receivable, Total	585M	1.28B	3.56B	5.17B	4.61B
Other Receivables	281M	682K	111M	85.32M	49.89M
Total Receivables	866M	1.29B	3.67B	5.25B	4.66B
Inventory	454M	1.34B	2.66B	4.52B	5.53B
Restricted Cash	461M	2.33B	610M	106M	3.17B
Other Current Assets, Total	636M	1.68B	2.09B	2.34B	2.32B
Total Current Assets	4.96B	39.68B	48.83B	43.53B	54.52B
Gross Property Plant And Equipment	3.83B	4B	7.99B	14.35B	15.56B
Accumulated Depreciation	-162M	-456M	-1B	-1.79B	-3.15B
Net Property Plant And Equipment	3.67B	3.54B	6.99B	12.56B	12.41B
Long-term Investments	-	1M	4.77B	9.22B	5.12B
Goodwill	-	-	-	-	34.11M
Other Intangibles, Total	373M	858M	1.47B	3.79B	7.74B
Accounts Receivable Long-Term	110M	397M	1.86B	2.19B	3.23B
Other Long-Term Assets, Total	138M	229M	1.73B	201M	1.1B
Total Assets	9.25B	44.71B	65.65B	71.49B	84.16B
Liabilities
Accounts Payable, Total	954M	5.11B	12.36B	14.22B	22.21B
Accrued Expenses, Total	589M	742M	2.19B	1.48B	3.02B
Short-term Borrowings	420M	128M	-	2.42B	3.89B
Current Portion of Long-Term Debt	60M	45M	-	762M	1.91B
Current Portion of Leases	90.74M	120M	373M	619M	400M
Current Income Taxes Payable	-	1.21M	22.74M	27.66M	5.74M
Unearned Revenue Current, Total	16.38M	169M	418M	389M	631M
Other Current Liabilities	1.17B	1.52B	2.64B	4.2B	4.05B
Total Current Liabilities	3.3B	7.84B	18.01B	24.11B	36.11B
Long-Term Debt	1.69B	1.64B	3.38B	6.38B	6.93B
Long-Term Leases	361M	353M	1.19B	2.65B	2.27B
Unearned Revenue Non Current	116M	362M	653M	1.01B	791M
Deferred Tax Liability Non Current	-	-	-	-	404M
Other Non Current Liabilities	923M	79.76M	266M	425M	1.33B
Total Liabilities	6.39B	10.28B	23.5B	34.58B	47.83B
Preferred Stock Convertible	9.69B	-	-	-	-
Total Preferred Equity	9.69B	-	-	-	-
Common Stock, Total	21K	101K	112K	114K	125K
Additional Paid In Capital	-	46.48B	59.98B	60.69B	70.2B
Retained Earnings	-6.82B	-11.32B	-16.19B	-25.32B	-35.7B
Treasury Stock	-	-	-	-1K	-1K
Comprehensive Income and Other	-5.95M	-730M	-1.65B	1.54B	1.83B
Total Common Equity	-6.83B	34.43B	42.15B	36.91B	36.33B
Total Equity	2.86B	34.43B	42.15B	36.91B	36.33B
Total Liabilities And Equity	9.25B	44.71B	65.65B	71.49B	84.16B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	181M	768M	850M	861M	943M
ECS Total Common Shares Outstanding	181M	768M	850M	860M	942M
Book Value / Share	-37.66	44.81	49.56	42.91	38.57
Tangible Book Value	-7.2B	33.57B	40.67B	33.12B	28.56B
Tangible Book Value Per Share	-39.72	43.69	47.82	38.5	30.31
Total Debt	2.62B	2.29B	4.95B	12.83B	15.39B
Net Debt	79.13M	-30.75B	-34.85B	-18.48B	-23.45B
Debt Equivalent Oper. Leases	1.03B	1.29B	3.63B	7.29B	6.57B
Equity Method Investments, Total	-	-	-	365M	553M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	126M	388M	1.61B	1.45B	1.83B
Inventories - Work In Process, Total	-	11.56M	14M	12.21M	30.83M
Inventories - Finished Goods, Total	328M	944M	1.04B	3.06B	3.66B
Buildings, Total	-	727M	861M	-	4.13B
Machinery, Total	975M	2.4B	3.17B	7.45B	8.11B
Full Time Employees	3.72K	5.08K	13.98K	15.83K	13.55K
Accumulated Allowance for Doubtful Accounts (Supple)	3.81M	-	-	-	-

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	-3.69B	-2.73B	-4.86B	-9.14B	-10.38B
Depreciation & Amortization - CF	214M	412M	802M	1.29B	1.83B
Amortization of Goodwill and Intangible Assets - (CF)	13M	25.49M	35.52M	50.31M	279M
Depreciation & Amortization, Total	227M	438M	838M	1.34B	2.11B
Amortization of Deferred Charges, Total - (CF)	-	-	-	65.71M	-
(Gain) Loss From Sale Of Asset	1.19M	6.17M	36.51M	15.68M	5.27M
(Gain) Loss on Sale of Investments - (CF)	-	-	-592M	-25.06M	224M
Asset Writedown & Restructuring Costs	79.18M	63.25M	34.59M	57.27M	90.53M
Provision for Credit Losses	833K	3.45M	49.98M	43.97M	47.35M
(Income) Loss On Equity Investments - (CF)	-	-	-	-4.12M	-54.74M
Stock-Based Compensation (CF)	517K	996M	380M	710M	551M
Provision and Write-off of Bad Debts	3.81M	6.22M	16.18M	11.37M	18.22M
Other Operating Activities, Total	6.68M	-1.42B	-579M	1.4B	991M
Change In Accounts Receivable	-505M	-596M	-1.56B	-1.21B	1.14B
Change In Inventories	-394M	-982M	-1.94B	-2.48B	-2.36B
Change In Accounts Payable	739M	4.16B	7.25B	1.86B	7.96B
Change in Unearned Revenues	83.13M	223M	589M	186M	217M
Change In Income Taxes	-	1.21M	21.53M	4.92M	-21.91M
Change In Deferred Taxes	-	-	-	-	18.8M
Change in Other Net Operating Assets	-113M	-310M	-776M	-1.07B	403M
Cash from Operations	-3.56B	-140M	-1.09B	-8.23B	956M
Capital Expenditure	-1.93B	-806M	-2.32B	-4.28B	-2.1B
Sale of Property, Plant, and Equipment	263K	24.5M	24.12M	77.06M	8.38M
Cash Acquisitions	-	-	-	-	-510M
Divestitures	-	-	-	-	684M
Sale (Purchase) of Intangible assets	-76.76M	-556M	-2.02B	-404M	-215M
Investment in Marketable and Equity Securities, Total	2.67B	-3.31B	-25.85B	13.09B	5.78B
Other Investing Activities, Total	83.2M	244M	-2.91B	-3.65B	-3.02B
Cash from Investing	740M	-4.41B	-33.08B	4.85B	631M
Short Term Debt Issued, Total	-	1.06B	-	-	-
Long-Term Debt Issued, Total	1.62B	1.03B	840M	6.8B	8.27B
Total Debt Issued	1.62B	2.09B	840M	6.8B	8.27B
Short Term Debt Repaid, Total	-	-1.06B	-	-	-
Long-Term Debt Repaid, Total	-748M	-1.38B	-983M	-795M	-5.28B
Total Debt Repaid	-748M	-2.44B	-983M	-795M	-5.28B
Issuance of Common Stock	-	27.4B	13.15B	-	5.02B
Issuance of Preferred Stock	2.68B	7.28B	-	-	-
Repurchase of Preferred Stock	-55M	-	-	-	-
Other Financing Activities, Total	98.01M	-	1.62B	-1.83M	-
Cash from Financing	3.59B	34.33B	14.63B	6B	8.02B
Foreign Exchange Rate Adjustments	5.12M	-650M	-363M	462M	-14.58M
Net Change in Cash	776M	29.13B	-19.91B	3.08B	9.59B
Supplemental Items
Cash Interest Paid	26.41M	76.09M	126M	162M	307M
Cash Income Tax Paid (Refund)	-	-	-	-	25.73M
Levered Free Cash Flow	-3.04B	-1.99B	372M	-8.57B	-453M
Unlevered Free Cash Flow	-3.02B	-1.98B	407M	-8.49B	-285M
Change In Net Working Capital	-1.07B	-596M	-7.7B	511M	-6.14B
Net Debt Issued / Repaid	872M	-352M	-143M	6.01B	3B

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	-27.34	-9.8	-7.56	-7.91	-8.7
Return on Total Capital	-39.11	-12.27	-9.96	-11.2	-13.35
Return On Equity %	-96.42	-14.31	-12.7	-23.12	-28.33
Return on Common Equity	102.99	-35.43	-12.7	-23.12	-28.33
Margin Analysis
Gross Profit Margin %	-20.63	5.63	12.66	11.62	1.74
SG&A Margin	50.17	49.97	25.28	24.9	21.38
EBITDA Margin %	-153.49	-66.77	-28.92	-28.71	-29.05
EBITA Margin %	-158.9	-71.95	-31.65	-32.11	-34.42
EBIT Margin %	-159.46	-72.39	-31.82	-32.3	-35.33
Income From Continuing Operations Margin %	-159.04	-46.75	-23.17	-34.03	-33.82
Net Income Margin %	-159.04	-46.75	-23.17	-34.03	-33.82
Net Avail. For Common Margin %	-200.01	-83.67	-23.17	-34.03	-33.82
Normalized Net Income Margin	-97.27	-28.53	-16.46	-21.2	-20.5
Levered Free Cash Flow Margin	-131.05	-34.05	1.77	-31.93	-1.48
Unlevered Free Cash Flow Margin	-130.19	-33.81	1.94	-31.62	-0.93
Asset Turnover
Asset Turnover	0.27	0.22	0.38	0.39	0.39
Fixed Assets Turnover	0.95	1.62	3.99	2.75	2.46
Receivables Turnover (Average Receivables)	7.45	6.25	8.66	6.15	6.28
Inventory Turnover (Average Inventory)	8.98	6.14	9.15	6.61	6
Short Term Liquidity
Current Ratio	1.5	5.06	2.71	1.81	1.51
Quick Ratio	1.03	4.38	2.41	1.52	1.2
Operating Cash Flow to Current Liabilities	-1.08	-0.02	-0.06	-0.34	0.03
Days Sales Outstanding (Average Receivables)	49.02	58.55	42.13	59.31	58.16
Days Outstanding Inventory (Average Inventory)	40.63	59.63	39.87	55.23	60.83
Average Days Payable Outstanding	69.15	173.33	162.29	189.56	213.47
Cash Conversion Cycle (Average Days)	20.5	-55.15	-80.28	-75.01	-94.47
Long Term Solvency
Total Debt/Equity	91.58	6.65	11.74	34.76	42.37
Total Debt / Total Capital	47.8	6.24	10.5	25.79	29.76
LT Debt/Equity	71.65	5.8	10.85	24.46	25.31
Long-Term Debt / Total Capital	37.4	5.44	9.71	18.15	17.78
Total Liabilities / Total Assets	69.05	22.99	35.8	48.37	56.84
EBIT / Interest Expense	-115.61	-188.43	-120.68	-65.62	-40.34
EBITDA / Interest Expense	-107.28	-166.61	-101.48	-51.42	-30.12
(EBITDA - Capex) / Interest Expense	-167.61	-202.52	-143.46	-83.77	-37.92
Total Debt / EBITDA	-0.76	-0.61	-0.88	-1.89	-1.9
Net Debt / EBITDA	-0.02	8.22	6.21	2.72	2.9
Total Debt / (EBITDA - Capex)	-0.49	-0.5	-0.62	-1.16	-1.51
Net Debt / (EBITDA - Capex)	-0.01	6.76	4.39	1.67	2.3
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	23.82K	151.78	259.12	27.95	14.23
Gross Profit, 1 Yr. Growth %	20.19K	-168.74	707.05	17.39	-82.91
EBITDA, 1 Yr. Growth %	118.12	9.52	55.53	27.02	16.6
EBITA, 1 Yr. Growth %	118.63	14.01	57.96	29.84	23.36
EBIT, 1 Yr. Growth %	118.42	14.29	57.85	29.91	24.93
Earnings From Cont. Operations, 1 Yr. Growth %	163.91	-26	78.01	87.92	13.53
Net Income, 1 Yr. Growth %	163.91	-26	78.01	87.92	13.53
Normalized Net Income, 1 Yr. Growth %	158.25	-26.16	107.19	64.8	10.47
Diluted EPS Before Extra, 1 Yr. Growth %	94.54	-51.21	-54.34	80.28	11.68
Accounts Receivable, 1 Yr. Growth %	1.42K	119.64	177.11	45.13	-10.81
Inventory, 1 Yr. Growth %	168.19	195.74	98.2	69.85	22.22
Net Property, Plant and Equip., 1 Yr. Growth %	204.45	-3.47	97.19	79.81	-1.2
Total Assets, 1 Yr. Growth %	20.57	383.25	46.85	8.9	17.72
Tangible Book Value, 1 Yr. Growth %	188.76	-566.04	21.15	-18.57	-13.78
Common Equity, 1 Yr. Growth %	212.57	-604.06	22.41	-12.42	-1.58
Cash From Operations, 1 Yr. Growth %	126.54	-96.08	683.16	652.1	-111.61
Capital Expenditures, 1 Yr. Growth %	150.75	-58.27	188.17	84.08	-50.97
Levered Free Cash Flow, 1 Yr. Growth %	-	-34.59	-118.69	-2.41K	-94.72
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-34.62	-120.57	-2.19K	-96.65
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %